TAMILARASI KANNAN: Open Payments
NPI 1487628657 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,613 in 90 payments from 18 companies in 2025. Trend: 2023 $1,971 · 2024 $2,396 · 2025 $1,613
Food & beverage: $1,613
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $277 |
| AstraZeneca Pharmaceuticals LP | 11 | $199 |
| Bayer Healthcare Pharmaceuticals Inc. | 11 | $158 |
| PFIZER INC. | 7 | $139 |
| Lilly USA, LLC | 7 | $130 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $119 |
| Astellas Pharma US Inc | 5 | $109 |
| Sumitomo Pharma America, Inc. | 4 | $106 |
| GlaxoSmithKline, LLC. | 5 | $88 |
| Amgen Inc. | 4 | $76 |
Products named: Kerendia, MOUNJARO, Wegovy, JARDIANCE, Ozempic, Veozah, NURTEC ODT, GEMTESA.
Industry payments across NC — which companies pay providers there.
